Skip to main content
Top
Published in: BMC Oral Health 1/2021

Open Access 01-12-2021 | Hypophosphatasia | Case report

Dental effects of enzyme replacement therapy in case of childhood-type hypophosphatasia

Authors: Rena Okawa, Kazuma Kokomoto, Kazuhiko Nakano

Published in: BMC Oral Health | Issue 1/2021

Login to get access

Abstract

Background

Hypophosphatasia (HPP), a skeletal disease characterized by hypomineralization of bone and teeth, is caused by an ALPL gene mutation that leads to low activity of the tissue non-specific alkaline phosphatase enzyme. Although enzyme replacement therapy (ERT) was recently introduced for affected patients, no known studies have been reported regarding its dental effects related to permanent teeth and jaw bones. In the present study, we examined the dental effects of ERT in a case of childhood-type hypophosphatasia, including panoramic radiography findings used to estimate the dental age of permanent teeth and mandibular bone density. Furthermore, the effects of that therapy on the periodontal condition of the patient were evaluated by comparing periodontal pocket depth before and after initiation.

Case presentation

An 11-year-1-month-old boy was referred to our clinic for consultation regarding oral management. Two primary incisors had spontaneously exfoliated at 1 year 8 months old and he had been diagnosed with childhood-type HPP at the age of 2 years 2 months. Obvious symptoms were localized in the dental region at the time of diagnosis, though later extended to other parts of the body such as bone pain. ERT was started at 11 years 7 months of age, after which bone pain disappeared, and motor functions and activities of daily living improved. We estimated dental age based on tooth development stage. The age gap between chronological and dental ages was expanded before treatment, and then showed a constant decrease after ERT initiation and finally disappeared. The index for mandibular bone density (mandibular cortical width / length from mesial buccal cusp to apex of first molar) was increased after ERT initiation. Furthermore, the periodontal condition for all teeth except those exfoliated was stable after starting therapy.

Conclusions

ERT resulted in improved tooth and mandibular bone mineralization, with notably good effects on teeth under formation. Acceleration of mineralization of roots associated with erupting teeth leads to stabilization of the periodontal condition. We concluded that ERT contributed to the improved dental condition seen in this patient.
Appendix
Available only for authorised users
Literature
1.
go back to reference Whyte MP, Zhang F, Wenkert D, McAlister WH, Mack KE, Benigno MC, et al. Hypophosphatasia: validation and expansion of the clinical nosology for children from 25 years experience with 173 pediatric patients. Bone. 2015;75:229–39.CrossRef Whyte MP, Zhang F, Wenkert D, McAlister WH, Mack KE, Benigno MC, et al. Hypophosphatasia: validation and expansion of the clinical nosology for children from 25 years experience with 173 pediatric patients. Bone. 2015;75:229–39.CrossRef
2.
go back to reference Whyte MP. Hypophosphatasia—aetiology, nosology, pathogenesis, diagnosis and treatment. Nat Rev Endocrinol. 2016;12(4):233–46.CrossRef Whyte MP. Hypophosphatasia—aetiology, nosology, pathogenesis, diagnosis and treatment. Nat Rev Endocrinol. 2016;12(4):233–46.CrossRef
3.
go back to reference Whyte MP, Wenkert D, Zhang F. Hypophosphatasia: Natural history study of 101 affected children investigated at one research center. Bone. 2016;93:125–38.CrossRef Whyte MP, Wenkert D, Zhang F. Hypophosphatasia: Natural history study of 101 affected children investigated at one research center. Bone. 2016;93:125–38.CrossRef
5.
go back to reference Okawa R, Nakano K, Matsumoto M, Kawabata K, Ooshima T. Oral manifestations of patients with hypophosphatasia. Ped Dent J. 2012;22(2):155–62.CrossRef Okawa R, Nakano K, Matsumoto M, Kawabata K, Ooshima T. Oral manifestations of patients with hypophosphatasia. Ped Dent J. 2012;22(2):155–62.CrossRef
6.
go back to reference Bloch-Zupan A. Hypophosphatasia: diagnosis and clinical signs—a dental surgeon perspective. Int J Paediatr Dent. 2016;26:426–38.CrossRef Bloch-Zupan A. Hypophosphatasia: diagnosis and clinical signs—a dental surgeon perspective. Int J Paediatr Dent. 2016;26:426–38.CrossRef
7.
go back to reference Feeney C, Stanford N, Lee S, Barry S. Hypophosphatasia and the importance of the general dental practitioner—a case series and discussion of upcoming treatments. Br Dent J. 2018;224(12):937–43.CrossRef Feeney C, Stanford N, Lee S, Barry S. Hypophosphatasia and the importance of the general dental practitioner—a case series and discussion of upcoming treatments. Br Dent J. 2018;224(12):937–43.CrossRef
8.
go back to reference Okawa R, Kokomoto K, Kitaoka T, Kubota T, Watanabe A, Taketani T, et al. Japanese nationwide survey of hypophosphatasia reveals prominent differences in genetic and dental findings between odonto and non-odonto types. PLoS ONE. 2019;14(10):e0222931.CrossRef Okawa R, Kokomoto K, Kitaoka T, Kubota T, Watanabe A, Taketani T, et al. Japanese nationwide survey of hypophosphatasia reveals prominent differences in genetic and dental findings between odonto and non-odonto types. PLoS ONE. 2019;14(10):e0222931.CrossRef
9.
go back to reference Michigami T, Ohata Y, Fujiwara M, Mochizuki H, Adachi M, Kitaoka T, et al. Clinical practice guidelines for hypophosphatasia. Clin Pediatr Endocrinol. 2020;29:9–24.CrossRef Michigami T, Ohata Y, Fujiwara M, Mochizuki H, Adachi M, Kitaoka T, et al. Clinical practice guidelines for hypophosphatasia. Clin Pediatr Endocrinol. 2020;29:9–24.CrossRef
10.
go back to reference Whyte MP, Madson KL, Phillips D, Reeves AL, McAlister WH, Yakimoski A, et al. Asfotase alfa therapy for children with hypophosphatasia. JCI Insight. 2016;16,1(9):e85971. Whyte MP, Madson KL, Phillips D, Reeves AL, McAlister WH, Yakimoski A, et al. Asfotase alfa therapy for children with hypophosphatasia. JCI Insight. 2016;16,1(9):e85971.
11.
go back to reference Whyte MP. Hypophosphatasia: enzyme replacement therapy brings new opportunities and new challenges. J Bone Miner Res. 2017;32(4):667–75.CrossRef Whyte MP. Hypophosphatasia: enzyme replacement therapy brings new opportunities and new challenges. J Bone Miner Res. 2017;32(4):667–75.CrossRef
12.
go back to reference Kishnani PS, Del Angel G, Zhou S, Rush ET. Monitoring guidance for patients with hypophosphatasia treated with asfotase alfa. Mol Genet Metab. 2017;122(1–2):4–17.CrossRef Kishnani PS, Del Angel G, Zhou S, Rush ET. Monitoring guidance for patients with hypophosphatasia treated with asfotase alfa. Mol Genet Metab. 2017;122(1–2):4–17.CrossRef
13.
go back to reference Whyte MP, Simmons JH, Moseley S, Fujita K, Bishop N, Salmon N, et al. Asfotase alfa for infants and young children with hypophosphatasia: 7 year outcomes of a single-arm, open-label, phase 2 extension trial. Lancet Diabetes Endocrinol. 2019;7(2):93–105.CrossRef Whyte MP, Simmons JH, Moseley S, Fujita K, Bishop N, Salmon N, et al. Asfotase alfa for infants and young children with hypophosphatasia: 7 year outcomes of a single-arm, open-label, phase 2 extension trial. Lancet Diabetes Endocrinol. 2019;7(2):93–105.CrossRef
14.
go back to reference Kishnani PS, Rockman-Greenberg C, Rauch F, Bhatti MT, Moseley S, Denker AE, et al. Five-year efficacy and safety of asfotase alfa therapy for adults and adolescents with hypophosphatasia. Bone. 2019;121:149–62.CrossRef Kishnani PS, Rockman-Greenberg C, Rauch F, Bhatti MT, Moseley S, Denker AE, et al. Five-year efficacy and safety of asfotase alfa therapy for adults and adolescents with hypophosphatasia. Bone. 2019;121:149–62.CrossRef
15.
go back to reference Okazaki Y, Kitajima H, Mochizuki N, Kitaoka T, Michigami T, Ozono K. Lethal hypophosphatasia successfully treated with enzyme replacement from day 1 after birth. Eur J Pediatr. 2016;175(3):433–7.CrossRef Okazaki Y, Kitajima H, Mochizuki N, Kitaoka T, Michigami T, Ozono K. Lethal hypophosphatasia successfully treated with enzyme replacement from day 1 after birth. Eur J Pediatr. 2016;175(3):433–7.CrossRef
16.
go back to reference Kitaoka T, Tajima T, Nagasaki K, Kikuchi T, Yamamoto K, Michigami T, et al. Safety and efficacy with asfotase alfa in patients with hypophosphatasia: results from a Japanese clinical trial. Clin Endocrinol. 2017;87(1):10–9.CrossRef Kitaoka T, Tajima T, Nagasaki K, Kikuchi T, Yamamoto K, Michigami T, et al. Safety and efficacy with asfotase alfa in patients with hypophosphatasia: results from a Japanese clinical trial. Clin Endocrinol. 2017;87(1):10–9.CrossRef
17.
go back to reference Okawa R, Kokomoto K, Yamaura-Miyazaki N, Michigami T, Nakano K. Oral findings in patient with lethal hypophosphatasia with enzyme replacement therapy. Ped Dent J. 2017;27:153–6.CrossRef Okawa R, Kokomoto K, Yamaura-Miyazaki N, Michigami T, Nakano K. Oral findings in patient with lethal hypophosphatasia with enzyme replacement therapy. Ped Dent J. 2017;27:153–6.CrossRef
18.
go back to reference Okawa R, Matayoshi S, Kariya R, Ogaya Y, Nomura R, Nakano K. Effects of enzyme replacement therapy for primary teeth in a patient with infantile hypophosphatasia. J Clin Pediatr Dent. 2020;44(5):348–51.CrossRef Okawa R, Matayoshi S, Kariya R, Ogaya Y, Nomura R, Nakano K. Effects of enzyme replacement therapy for primary teeth in a patient with infantile hypophosphatasia. J Clin Pediatr Dent. 2020;44(5):348–51.CrossRef
19.
go back to reference Okawa R, Miura J, Kokomoto K, Kubota T, Kitaoka T, Ozono K, et al. Early exfoliation of permanent tooth in patient with hypophosphatasia. Ped Dent J. 2017;27(3):173–8.CrossRef Okawa R, Miura J, Kokomoto K, Kubota T, Kitaoka T, Ozono K, et al. Early exfoliation of permanent tooth in patient with hypophosphatasia. Ped Dent J. 2017;27(3):173–8.CrossRef
20.
go back to reference Haavikko K. The formation and the alveolar and clinical eruption of the permanent teeth. An orthopantomographic study. Suom Hammaslaak Toim. 1970;66:103–70.PubMed Haavikko K. The formation and the alveolar and clinical eruption of the permanent teeth. An orthopantomographic study. Suom Hammaslaak Toim. 1970;66:103–70.PubMed
21.
go back to reference Nakano K, Matsuoka T, Takahashi A, Matsumura M, Sobue S, Ooshima T. Delayed development or congenital absence of a single first permanent molar in Japanese child patients. Int J Paed Dent. 1999;9:271–6.CrossRef Nakano K, Matsuoka T, Takahashi A, Matsumura M, Sobue S, Ooshima T. Delayed development or congenital absence of a single first permanent molar in Japanese child patients. Int J Paed Dent. 1999;9:271–6.CrossRef
22.
go back to reference Taguchi A. Panoramic radiographs for identifying individuals with undetected osteoporosis. Jpn Dent Sci Rev. 2009;15:109–20.CrossRef Taguchi A. Panoramic radiographs for identifying individuals with undetected osteoporosis. Jpn Dent Sci Rev. 2009;15:109–20.CrossRef
23.
go back to reference Klemetti E, Kolmakov S, Kröger H. Pantomography in assessment of the osteoporosis risk group. Scand Dent Res. 1994;102(1):68–72. Klemetti E, Kolmakov S, Kröger H. Pantomography in assessment of the osteoporosis risk group. Scand Dent Res. 1994;102(1):68–72.
24.
go back to reference Apolinário AC, Figueiredo PT, Guimarães AT, Acevedo AC, Castro LC, Paula AP, et al. Pamidronate affects the mandibular cortex of children with osteogenesis imperfecta. J Dent Res. 2015;94(3 Suppl):95S-102S.CrossRef Apolinário AC, Figueiredo PT, Guimarães AT, Acevedo AC, Castro LC, Paula AP, et al. Pamidronate affects the mandibular cortex of children with osteogenesis imperfecta. J Dent Res. 2015;94(3 Suppl):95S-102S.CrossRef
25.
go back to reference Apolinário AC, Sindeaux R, de Souza Figueiredo PT, Guimarães AT, Acevedo AC, Castro LC, et al. Dental panoramic indices and fractal dimension measurements in osteogenesis imperfecta children under pamidronate treatment. Dentomaxillofac Radiol. 2016;45(4):20150400.CrossRef Apolinário AC, Sindeaux R, de Souza Figueiredo PT, Guimarães AT, Acevedo AC, Castro LC, et al. Dental panoramic indices and fractal dimension measurements in osteogenesis imperfecta children under pamidronate treatment. Dentomaxillofac Radiol. 2016;45(4):20150400.CrossRef
Metadata
Title
Dental effects of enzyme replacement therapy in case of childhood-type hypophosphatasia
Authors
Rena Okawa
Kazuma Kokomoto
Kazuhiko Nakano
Publication date
01-12-2021
Publisher
BioMed Central
Published in
BMC Oral Health / Issue 1/2021
Electronic ISSN: 1472-6831
DOI
https://doi.org/10.1186/s12903-021-01673-2

Other articles of this Issue 1/2021

BMC Oral Health 1/2021 Go to the issue